Cancer Letters
Volume 225, Issue 1 , Pages 1-26, 8 July 2005

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

  • James G. Christensen

      Affiliations

    • Research Pharmacology, Pfizer Inc., La Jolla, CA 92121, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 858 638 6336; fax: +1 858 526 4275.
    • ,
  • Jon Burrows

      Affiliations

    • Rigel Inc. Pharmacology Department, South San Francisco, CA 94080, USA
    • ,
  • Ravi Salgia

      Affiliations

    • Section of Hematology/Oncology, Department of Medicine, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, IL 60637, USA

Received 20 September 2004; accepted 29 September 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(04)00765-7

doi:10.1016/j.canlet.2004.09.044

Cancer Letters
Volume 225, Issue 1 , Pages 1-26, 8 July 2005

Article Tools

* Image Usage & Resolution